Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 6,413,000 | 3,156,000 | 13,967,000 | 11,563,000 | 7,633,000 |
| Depreciation Amortization | 2,614,000 | 1,208,000 | 5,275,000 | 3,739,000 | 2,447,000 |
| Income taxes - deferred | 1,695,000 | 683,000 | 2,385,000 | 1,571,000 | 1,305,000 |
| Accounts receivable | -760,000 | -504,000 | -1,124,000 | -1,030,000 | -1,210,000 |
| Accounts payable and accrued liabilities | -237,000 | -53,000 | -273,000 | -375,000 | -315,000 |
| Other Working Capital | -555,000 | -787,000 | -1,577,000 | 10,000 | -1,326,000 |
| Other Operating Activity | 388,000 | -27,000 | 491,000 | 1,402,000 | 1,775,000 |
| Operating Cash Flow | $9,558,000 | $3,676,000 | $19,144,000 | $16,880,000 | $10,309,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 796,000 | 1,099,000 | 1,781,000 | 1,770,000 | 1,808,000 |
| PPE Investments | -636,000 | -341,000 | -1,535,000 | -927,000 | -574,000 |
| Net Acquisitions | -11,644,000 | -12,043,000 | -235,000 | -214,000 | -142,000 |
| Purchase Of Investment | -40,000 | N/A | -116,000 | -63,000 | -40,000 |
| Sale Of Investment | 86,000 | 37,000 | 209,000 | 185,000 | 45,000 |
| Purchase Sale Intangibles | -898,000 | -485,000 | -2,188,000 | -1,892,000 | -1,467,000 |
| Other Investing Activity | -3,403,000 | -488,000 | -4,981,000 | -3,524,000 | -3,010,000 |
| Investing Cash Flow | $-14,841,000 | $-11,736,000 | $-4,877,000 | $-2,773,000 | $-1,913,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 955,000 | 747,000 | 5,000 | 842,000 | 1,406,000 |
| Debt Issued | 12,900,000 | 10,918,000 | 6,098,000 | 135,000 | N/A |
| Debt Repayment | -39,000 | N/A | N/A | -1,622,000 | -1,613,000 |
| Common Stock Issued | 14,000 | N/A | 27,000 | 23,000 | 21,000 |
| Common Stock Repurchased | -3,074,000 | -1,875,000 | -9,212,000 | -7,732,000 | -5,430,000 |
| Dividend Paid | -9,068,000 | -6,197,000 | -7,818,000 | -7,818,000 | -7,818,000 |
| Other Financing Activity | -129,000 | -14,000 | -3,967,000 | -378,000 | -327,000 |
| Financing Cash Flow | $1,559,000 | $3,579,000 | $-14,867,000 | $-16,550,000 | $-13,761,000 |
| Exchange Rate Effect | -95,000 | -77,000 | 576,000 | 540,000 | 562,000 |
| Beginning Cash Position | 11,435,000 | 11,435,000 | 11,459,000 | 11,459,000 | 11,459,000 |
| End Cash Position | 7,616,000 | 6,877,000 | 11,435,000 | 9,556,000 | 6,656,000 |
| Net Cash Flow | $-3,819,000 | $-4,558,000 | $-24,000 | $-1,903,000 | $-4,803,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,558,000 | 3,676,000 | 19,144,000 | 16,880,000 | 10,309,000 |
| Capital Expenditure | -667,000 | -346,000 | -1,548,000 | -939,000 | -585,000 |
| Free Cash Flow | 8,891,000 | 3,330,000 | 17,596,000 | 15,941,000 | 9,724,000 |